Cargando…

Polymerized human hemoglobin increases the effectiveness of cisplatin-based chemotherapy in non-small cell lung cancer

Cisplatin is a promising therapeutic for the treatment of non-small cell lung cancer (NSCLC). Unfortunately, a significant portion of NSCLC patients relapse due to cisplatin chemoresistance. This chemoresistance is thought to be primarily associated with hypoxia in the tumor microenvironment. Admini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lucas, Alfredo, Belcher, Donald A., Munoz, Carlos, Williams, Alexander T., Palmer, Andre F., Cabrales, Pedro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584239/ https://www.ncbi.nlm.nih.gov/pubmed/33144918 http://dx.doi.org/10.18632/oncotarget.27776

Ejemplares similares

Polymerized human hemoglobin facilitated modulation of tumor oxygenation is dependent on tumor oxygenation status and oxygen affinity of the hemoglobin-based oxygen carrier
por: Belcher, Donald A., et al.
Publicado: (2020)

Tumor vascular status controls oxygen delivery facilitated by infused polymerized hemoglobins with varying oxygen affinity
por: Belcher, Donald A., et al.
Publicado: (2020)

Polymerized albumin restores impaired hemodynamics in endotoxemia and polymicrobial sepsis
por: Belcher, Donald A., et al.
Publicado: (2021)

Mixtures of tense and relaxed state polymerized human hemoglobin regulate oxygen affinity and tissue construct oxygenation
por: Belcher, Donald Andrew, et al.
Publicado: (2017)

Next‐generation polymerized human hemoglobins in hepatic bioreactor simulations
por: Cuddington, Clayton, et al.
Publicado: (2020)

Resuscitation from hemorrhagic shock after traumatic brain injury with polymerized hemoglobin
por: Muller, Cynthia R., et al.
Publicado: (2021)

Safety and efficacy of human polymerized hemoglobin on guinea pig resuscitation from hemorrhagic shock
por: Muller, Cynthia R., et al.
Publicado: (2022)

Biocompatibility of the oxygen carrier polymerized human hemoglobin towards HepG2/C3A cells
por: Chen, Nuozhou, et al.
Publicado: (2023)

Increased Hemoglobin Oxygen Affinity With 5-Hydroxymethylfurfural Supports Cardiac Function During Severe Hypoxia
por: Lucas, Alfredo, et al.
Publicado: (2019)

Evaluating the Capacity to Generate and Preserve Nitric Oxide Bioactivity in Highly Purified Earthworm Erythrocruorin: A GIANT POLYMERIC HEMOGLOBIN WITH POTENTIAL BLOOD SUBSTITUTE PROPERTIES
por: Roche, Camille J., et al.
Publicado: (2015)

The quaternary state of polymerized human hemoglobin regulates oxygenation of breast cancer solid tumors: A theoretical and experimental study
por: Belcher, Donald A., et al.
Publicado: (2018)

Pilot scale production and characterization of next generation high molecular weight and tense quaternary state polymerized human hemoglobin
por: Cuddington, Clayton T., et al.
Publicado: (2022)

Polyethylene Glycol Camouflaged Earthworm Hemoglobin
por: Jani, Vivek P., et al.
Publicado: (2017)

A hemoglobin-based oxygen carrier sensitized Cisplatin based chemotherapy in hepatocellular carcinoma
por: Qi, Xiang, et al.
Publicado: (2017)

Renal glomerular and tubular responses to glutaraldehyde- polymerized human hemoglobin
por: Williams, Matthew C., et al.
Publicado: (2023)

Determinants of Myelosuppression in the Treatment of Non‐small Cell Lung Cancer with Cisplatin‐containing Chemotherapy
por: Matsui, Kaoru, et al.
Publicado: (1996)

Numerical Model for the Determination of Erythrocyte Mechanical Properties and Wall Shear Stress in vivo From Intravital Microscopy
por: Jani, Vivek P., et al.
Publicado: (2020)

Triplet chemotherapy combination with cisplatin, gemcitabine and docetaxel in patients with chemotherapy-naive advanced non-small cell lung cancer
por: TAS, FARUK, et al.
Publicado: (2013)

Doxorubicin-loaded red blood cells reduced cardiac toxicity and preserved anticancer activity
por: Lucas, Alfredo, et al.
Publicado: (2019)

The Role of Epigenetics in Resistance to Cisplatin Chemotherapy in Lung Cancer
por: O'Byrne, Kenneth J., et al.
Publicado: (2011)

Impact of hemoglobin nitrite to nitric oxide reductase on blood transfusion for resuscitation from hemorrhagic shock
por: Brouse, Chad, et al.
Publicado: (2015)

Synergistic Antitumor Efficacy Mediated by Liposomal Co-Delivery of Polymeric Micelles of Vinorelbine and Cisplatin in Non-Small Cell Lung Cancer
por: Wang, Shuhang, et al.
Publicado: (2021)

Trial on Refinement of Early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: The TREAT protocol
por: Kreuter, Michael, et al.
Publicado: (2007)

Preoperative induction chemotherapy with cisplatin and irinotecan for pathological N(2) non-small cell lung cancer
por: Date, H, et al.
Publicado: (2002)

A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in small-cell lung cancer.
por: Hickish, T. F., et al.
Publicado: (1998)

Combination Chemotherapy with Cyclophosphamide, Vincristine, Cisplatin and Etoposide(COPE) Combined with Radiotherapy for Small Cell Lung Cancer
por: Nam, Yong Jin, et al.
Publicado: (1995)

Cisplatin-Based Chemotherapy Is a Strong Risk Factor for Thromboembolic Events in Small-Cell Lung Cancer
por: Lee, Yun-Gyoo, et al.
Publicado: (2015)

Gemcitabine combined with cisplatin as adjuvant chemotherapy for non‐small cell lung cancer: A retrospective analysis
por: Ma, Di, et al.
Publicado: (2017)

Synchronous Microwave Ablation Combined With Cisplatin Intratumoral Chemotherapy for Large Non-Small Cell Lung Cancer
por: Huang, Guanghui, et al.
Publicado: (2022)

Chemotherapy of non-small cell lung cancer.
por: Williams, C. J.
Publicado: (1989)

Blood pressure reduction due to hemoglobin glycosylation in type 2 diabetic patients
por: Cabrales, Pedro, et al.
Publicado: (2008)

Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer.
por: Ellis, P. A., et al.
Publicado: (1995)

Chemotherapy with cisplatin and vinorelbine for elderly patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC)
por: Pereira, José Rodrigues, et al.
Publicado: (2004)

The effect of HER2 expression on cisplatin-based chemotherapy in advanced non-small cell lung cancer patients
por: Calikusu, Zuleyha, et al.
Publicado: (2009)

A Case of Typhlitis Developed after Chemotherapy with Irinotecan and Cisplatin in a Patient with Small Cell Lung Carcinoma
por: Ji, Eun Hye, et al.
Publicado: (2012)

Elevated Stratifin promotes cisplatin-based chemotherapy failure and poor prognosis in non-small cell lung cancer
por: Ma, Yu-Shui, et al.
Publicado: (2021)

Identification of a Small Molecule that Increases Hemoglobin Oxygen Affinity and Reduces SS Erythrocyte Sickling
por: Nakagawa, Akito, et al.
Publicado: (2014)

Demethoxycurcumin increases the sensitivity of cisplatin-resistant non-small lung cancer cells to cisplatin and induces apoptosis by activating the caspase signaling pathway
por: Chen, Yun, et al.
Publicado: (2020)

Increased MALAT1 expression contributes to cisplatin resistance in non-small cell lung cancer
por: Cui, Yong, et al.
Publicado: (2018)

Increased ABCC2 expression predicts cisplatin resistance in non‐small cell lung cancer
por: Chen, Yun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cot68c435nvn30tajubekekur3